Status: Not yet recruiting
A Study of the Safety, Tolerability, Pharmacokinetics and Efficacy of KIT2014 in Patients With Moderate to Severe COPD
Study investigating the safety, tolerability, pharmacokinetics and early efficacy with KIT2014 over 7 days of treatment in moderate to severe chronic obstructive pulmonary disease patients.
Participants needed: 36
Trial details
Phase: Phase 1, Phase 2Age: 40-80Biological sex: AllType: InterventionalSponsor: Kither Biotech SrlUpdated: Jun 25, 2026Locations: 1
Eligibility criteria
Must have given written informed consent before any study-related activities are... [+5]
History of life-threatening COPD [+2]